Wed, Sep 17, 2014, 8:42 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Soligenix, Inc. Message Board

  • litfaa litfaa Feb 1, 2013 3:51 PM Flag

    News should be out soon on full year results

    Monday, February 06, 2012

    Soligenix Demonstrates Positive Proof of Concept with its Proprietary Vaccine Thermostabilization Technology

    Research Conducted under Existing $9.4 Million NIAID Thermostability Grant

    Princeton, NJ – February 6, 2012 – Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.

    Sentiment: Strong Buy

0.600.00(0.00%)Mar 7 10:14 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.